Skip to content

Performance Evaluation of U-Lab Diapers; A new screening method for urinary tract infections in diaper wearing children

Performance Evaluation of U-Lab Diapers; A new screening method for urinary tract infections in diaper wearing children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003143
Enrollment
250
Registered
2011-06-28
Start date
2009-05-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N39.0

Interventions

Group 1: Urine collection and concommitant detection of nitrites and leukocytes by the device U-Lab diapers/U-Test Group 2: control arm with reference methode: Urine collection with urine bag or other

Sponsors

Swiss Medical Solution AG
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 5 Years

Inclusion criteria

Inclusion criteria: - Diaper wearing children under the age of five

Exclusion criteria

Exclusion criteria: - Infants in critical health, for which the application of U-Lab Diapers could interfere with the healing process: Specifically children that present skin lesions or dermatological problems in the genital or sitting area.

Design outcomes

Primary

MeasureTime frame
1) The test can function under real condition with patients. Enough urine enters the test chamber. The test is evaluated after the child has urinated or after 3h at the latest Measurement: The color chance of the validity indicator from green to orange. The color change is reported in the case report form. The percentage of functioning tests is calculated at the end of the study.

Secondary

MeasureTime frame
1)Device gives the same conclusion than the Reference method (dipstick measurements performed with bag urine etc). Measurement: The color change of the nitrite und leukocyte indicators in the new test system and on the reference dipstick, respectively. The results are reported in the case report form. Performance parameters of sensitivity and specificity are calculated 2)The Patients show no skin irritation or other undesired side effect due to the new test device. Measurement: Observation by the responsible phyisician. The observations of the presence or absence of undesired effects are reported in the case report forms.

Countries

Switzerland

Contacts

Public ContactJean-Daniel Krähenbühl

Paediatician office Dr. Krähenbühl

jdkped@bluewin.ch+41 21 653 43 51

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026